Maryland Senate and House / 2026 Regular Session

HB1461: Health Insurance - Coverage for Specialty Drugs - Rheumatologic Conditions

In the House - Hearing 3/13 at 1:30 p.m.

Altering the circumstances under which certain insurers, nonprofit health service plans, and health maintenance organizations are prohibited from excluding coverage for certain specialty drugs for the treatment of rheumatologic conditions.

Official bill page · Source: Maryland General Assembly

Ask about HB1461

Legislative actions

No action history has been imported for this bill. This does not mean the bill had no actions.

Raw source record
{
    "Title": "Health Insurance - Coverage for Specialty Drugs - Rheumatologic Conditions",
    "Status": "In the House - Hearing 3\/13 at 1:30 p.m.",
    "BillType": "Regular",
    "Sponsors": [
        {
            "Name": "Delegate Taveras"
        },
        {
            "Name": "Delegate Lehman"
        },
        {
            "Name": "Delegate Williams"
        }
    ],
    "Statutes": [
        {
            "Article": {
                "Code": "gin",
                "Title": "Insurance"
            },
            "Sections": [
                {
                    "Section": "15-847.2"
                }
            ]
        }
    ],
    "Synopsis": "Altering the circumstances under which certain insurers, nonprofit health service plans, and health maintenance organizations are prohibited from excluding coverage for certain specialty drugs for the treatment of rheumatologic conditions.",
    "BillNumber": "HB1461",
    "BillVersion": "F",
    "PassedByMGA": false,
    "BroadSubjects": [
        {
            "Code": "j5",
            "Name": "Health - Insurance"
        }
    ],
    "ChapterNumber": "",
    "EmergencyBill": false,
    "NarrowSubjects": [
        {
            "Code": "drugs",
            "Name": "Drugs -see also- Cannabis; ControlDangSubst; Pharm; etc."
        },
        {
            "Code": "health",
            "Name": "Health -see also- COVID19; EnvHlth; MedCon; etc."
        },
        {
            "Code": "healthi",
            "Name": "Health Insurance -see also- ACA; HMOs; MCOs"
        },
        {
            "Code": "healthmo",
            "Name": "Health Maintenance Organizations -see also- Manage Care Orgs"
        },
        {
            "Code": "medicac",
            "Name": "Medical Conditions -see also- AIDS; COVID-19; rabies"
        },
        {
            "Code": "medicatr",
            "Name": "Medical Treatments"
        },
        {
            "Code": "nonproo",
            "Name": "Nonprofit Organizations"
        },
        {
            "Code": "pharmabm",
            "Name": "Pharmacy Benefits Managers"
        },
        {
            "Code": "pharmap",
            "Name": "Pharmacists and Pharmacies -see also- Drugs"
        }
    ],
    "SponsorPrimary": "Delegate Taveras",
    "YearAndSession": "2026 Regular Session",
    "StatusCurrentAsOf": "2026-11-13T11:57:19.330",
    "CrossfileBillNumber": "",
    "CommitteePrimaryOrigin": "Health",
    "ConstitutionalAmendment": false,
    "ReportDateHouseOfOrigin": null,
    "ReportDateOppositeHouse": null,
    "CommitteePrimaryOpposite": "",
    "CommitteeSecondaryOrigin": "",
    "ReportActionHouseOfOrigin": "",
    "ReportActionOppositeHouse": "",
    "CommitteeSecondaryOpposite": "",
    "InteractionBetweenChambers": "",
    "FirstReadingDateHouseOfOrigin": "2026-02-13",
    "FirstReadingDateOppositeHouse": null,
    "ThirdReadingDateHouseOfOrigin": null,
    "ThirdReadingDateOppositeHouse": null,
    "SecondReadingDateHouseOfOrigin": null,
    "SecondReadingDateOppositeHouse": null,
    "ThirdReadingActionHouseOfOrigin": "",
    "ThirdReadingActionOppositeHouse": "",
    "SecondReadingActionHouseOfOrigin": "",
    "SecondReadingActionOppositeHouse": "",
    "HearingDateTimePrimaryHouseOfOrigin": "2026-03-13T13:30:00",
    "HearingDateTimePrimaryOppositeHouse": null,
    "HearingDateTimeSecondaryHouseOfOrigin": null,
    "HearingDateTimeSecondaryOppositeHouse": null
}